The main goal of this multifacted proposal is to continue research on the mechanisms by which parathyroid hormone, PTH, paradoxically considered a catabolic hormone for bone, can stimulate bone growth in vivo. We have developed a reproducible in vivo model by giving intermittent synthetic human PTH 1-34 to young rats to increase bone mass and bone forming surfaces. A specific goal is to determine how factors associated with growth, such as growth hormone (GH), GH-dependent insulin-like growth factor (IGF-I) and nutrition regulate the PTH-induced anabolic response in young and aging rats. New models proposed include hypophysectomised rats, the use of somatostatin analog suppress GH and mice with genetic growth defects. A second specific goal is to use a new in vivo-in vivo protocol of the PTH-induced anabolic response to determine if PTH stimulates the secretion of local growth factors, specifically IGF-I and TGFbeta. Immunocytochemistry is being developed to localise sites of IGF-I and TGFbeta secretion in histologic bone sections. The third specific goal is to investigate bone cell kinetics to determine the effect of anabolic doses of PTH on osteoblast differentiation and osteoblast precursor replication. The techniques described include established and new in vivo and new in vivo-in vitro approaches, using chemical, biochemical, computer-assisted morphometric and autoradiographic methods I developed to assess changes in bone mass and growth, and applying recent developments in bone growth factor research. A new in vivo model to study the direct effects of PTH and local bone growth factors is proposed, using intra-arterial infusion of a rat hindlimb. Knowledge of the mechanisms and mediators regulating the anabolic effect of PTH would provide a more rational basis to justify the current use of PTH in the treatment of osteoporosis and might suggest new approaches to therapies to stimulate bone growth in a wide variety of patients with bone diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute of Dental & Craniofacial Research (NIDCR)
Type
Research Project (R01)
Project #
2R01DE007272-05A1
Application #
3220898
Study Section
Oral Biology and Medicine Study Section (OBM)
Project Start
1988-10-01
Project End
1992-06-30
Budget Start
1989-07-14
Budget End
1990-06-30
Support Year
5
Fiscal Year
1989
Total Cost
Indirect Cost
Name
Tufts University
Department
Type
Schools of Dentistry/Oral Hygn
DUNS #
604483045
City
Boston
State
MA
Country
United States
Zip Code
02111
Bidwell, J P; Alvarez, M; Feister, H et al. (1998) Nuclear matrix proteins and osteoblast gene expression. J Bone Miner Res 13:155-67
Alvarez, M; Thunyakitpisal, P; Morrison, P et al. (1998) PTH-responsive osteoblast nuclear matrix architectural transcription factor binds to the rat type I collagen promoter. J Cell Biochem 69:336-52
Torrungruang, K; Feister, H; Swartz, D et al. (1998) Parathyroid hormone regulates the expression of the nuclear mitotic apparatus protein in the osteoblast-like cells, ROS 17/2.8. Bone 22:317-24
Feister, H A; Swartz, D; Odgren, P R et al. (1997) Topoisomerase II expression in osseous tissue. J Cell Biochem 67:451-65
Alvarez, M; Long, H; Onyia, J et al. (1997) Rat osteoblast and osteosarcoma nuclear matrix proteins bind with sequence specificity to the rat type I collagen promoter. Endocrinology 138:482-9
Bidwell, J; McCabe, R; Rougraff, B et al. (1997) Tissue matrix protein expression in human osteoblasts, osteosarcoma tumors, and osteosarcoma cell lines. Mol Biol Rep 24:271-82
Bidwell, J; Feister, H; Swartz, D et al. (1996) Parathyroid hormone regulates the expression of rat osteoblast and osteosarcoma nuclear matrix proteins. J Cell Biochem 63:374-83
Hock, J M; Fonseca, J (1990) Anabolic effect of human synthetic parathyroid hormone-(1-34) depends on growth hormone. Endocrinology 127:1804-10